KARPAS 45 Human T-cell Leukaemia cell line

KARPAS 45 Human T-cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

Publications:

Smith et al. (1973). Lancet 301, 74–77

Borkhardt et al. (1997) Oncogene 14, 195–202

Drexler et al. (2004). Leukemia 18, 227–232

Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.